• 4043 Citations
  • 10 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jun Suk Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
gemcitabine Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Pain Measurement Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm RNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 4043 Citations
  • 10 h-Index
  • 21 Article
  • 1 Comment/debate
  • 1 Review article

TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

Ioka, T., Ueno, M., Ueno, H., Park, J. O., Chang, H. M., Sasahira, N., Kanai, M., Chung, I. J., Ikeda, M., Nakamori, S., Mizuno, N., Omuro, Y., Yamaguchi, T., Hara, H., Sugimori, K., Furuse, J., Maguchi, H., Furukawa, M., Fukuzawa, K., Kim, J. S. & 5 others, Yukisawa, S., Takeuchi, M., Okusaka, T., Boku, N. & Hyodo, I., 2019 Jan 1, In : European Journal of Cancer. 106, p. 78-88 11 p.

Research output: Contribution to journalArticle

Open Access
gemcitabine
Leucovorin
Pancreatic Neoplasms
Survival
Korea
Venous Thromboembolism
Pancreatic Neoplasms
Retrospective Studies
Drug Therapy
gemcitabine
1 Citation (Scopus)

Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?

Lee, C. M., Choi, I. K., Kim, J. H., Park, D. W., Kim, J. S. & Park, S-H., 2017 Jan 1, In : Annals of Surgical Treatment and Research. 92, 1, p. 23-29 7 p.

Research output: Contribution to journalArticle

Gastrectomy
Stomach Neoplasms
Drug Therapy
Survival
Cause of Death
1 Citation (Scopus)
gemcitabine
Proton Pump Inhibitors
Gastritis
Pancreatic Neoplasms
Radiation
14 Citations (Scopus)

Using modified RECIST and alpha-fetoprotein levels to assess treatment benefit in hepatocellular carcinoma

Raoul, J. L., Park, J. W., Kang, Y. K., Finn, R. S., Kim, J. S., Yeo, W., Polite, B. N., Chao, Y., Walters, I., Baudelet, C. & Lencioni, R., 2014 Apr 16, In : Liver Cancer. 3, 3-4, p. 439-450 12 p.

Research output: Contribution to journalReview article

alpha-Fetoproteins
Hepatocellular Carcinoma
Therapeutics
Fibroblast Growth Factors
Response Evaluation Criteria in Solid Tumors